EXPRESSION OF CALLA/CD10 ON HUMAN-MELANOMA CELLS

被引：36

作者：

CARREL, S

ZOGRAFOS, L

SCHREYER, M

RIMOLDI, D

机构：

[1] Ludwig Institute for Cancer Research, University of Lausanne, School of Medicine, University Hospital

来源：

MELANOMA RESEARCH | 1993年 / 3卷 / 05期

关键词：

CALLA/CD10; HUMAN MELANOMA; IMMUNOHISTOCHEMISTRY; MONOCLONAL ANTIBODY;

D O I：

10.1097/00008390-199310000-00003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The reactivity spectrum of an anti-CALLA/CD10 monoclonal antibody for cutaneous melanoma was analysed by immunohistochemistry in a series of lesions of different Breslow thickness. Similar proportions of small primary tumours, advanced primary tumours and metastatic lesions were found to express CALLA/CD10 (31-47%). However the proportion of stained cells within a given lesion increased with tumour progression. Up to 23% of the advanced primary lesions (>3.0 mm) showed 26-60% cells stained with the anti-CALLA/CD10 antibody and up to 14% of the metastatic lesions showed 76-100% stained cells. The expression of CALLA/CD10 was further analysed in 15 ocular melanoma lesions of different histiotype. All five spindle type lesions, three of six epitheloid and two of five mixed type lesions stained positively with the anti-CALLA/CD10 antibody. The percentage of stained cells within a given lesion varied from 30% to 100%. A total of 63% of the ocular melanomas and 38% of the cutaneous melanomas tested expressed CALLA/CD10. Experiments with cultured melanoma cell lines showed that the surface expression of CALLA/CD10 can be modulated in vitro by treatment with interleukin 2 (IL-2) and an adenosine 3',5'-cyclic monophosphate (analogue).

引用

页码：319 / 323

页数：5

共 23 条

[11]

Jongeneel C.V., Quackenbush E.J., Ronco P., The common acute lymphoblastic leukemia antigen (CALLA) expressed on leukemia and melanoma cell lines has neutral endopeptidase activity, J Clin Invest, 83, pp. 713-717, (1989)

[12]

Monod L., Diserens A.C., Jongeneel C.V., Human glioma cell lines expressing the common acute lymphoblastic leukemia antigen (CALLA) have neutral endopeptidase activity, Int J Cancer, 44, pp. 948-951, (1989)

[13]

Deschodt-Lanckman M., Vanneste Y., Loir B., Degradation of a-melanocyte stimulating hormone (Oc-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture, Int J Cancer, 46, pp. 1124-1130, (1990)

[14]

Pierart M.E., Najdovski T., Appelboom T.E., Effect of human endopeptidase 24.11 (‘enkephalinase’) on IL-1 induced thymocyte proliferation assay, J Immunol, 140, pp. 3808-3811, (1988)

[15]

Carrel S., Schreyer M., Gross N., Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma, Anticancer Res, 10, pp. 81-90, (1990)

[16]

Rimoldi D., Romero P., Carrel S., The human melanoma associated gene MAGE-1 is also expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas, Int J Cancer, 54, pp. 527-528, (1993)

[17]

Ziegler-Heitbrock H., Munker R., Johnson J., In vitro differentiation of human melanoma cells analyzed with monoclonal antibodies, Cancer Res, 45, pp. 1344-1350, (1985)

[18]

Giuffre L., Schreyer M., Mach J.-P., Cyclic AMP induces differentiation in vitro of human melanoma cells, Cancer, 61, pp. 1132-1141, (1988)

[19]

Breslow A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma, Ann Surg, 172, pp. 902-908, (1970)

[20]

Carrel S., Dore J.-F., Ruiter D.J., The EORTC melanoma group exchange program: Evaluation of a multicenter monoclonal antibody study, Int J Cancer, 48, pp. 836-847, (1991)

← 1 2 3 →